Cargando…
Rapid and Robust Multi-Phenotypic Assay System for ALS Using Human iPS Cells with Mutations in Causative Genes
Amyotrophic lateral sclerosis (ALS) is a major life-threatening disease caused by motor neuron degeneration. More effective treatments through drug discovery are urgently needed. Here, we established an effective high-throughput screening system using induced pluripotent stem cells (iPSCs). Using a...
Autores principales: | Kondo, Tosho, Ebinuma, Ihori, Tanaka, Hirotaka, Nishikawa, Yukitoshi, Komiya, Takaki, Ishikawa, Mitsuru, Okano, Hideyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138792/ https://www.ncbi.nlm.nih.gov/pubmed/37108151 http://dx.doi.org/10.3390/ijms24086987 |
Ejemplares similares
-
iPS cell technologies: significance and applications to CNS regeneration and disease
por: Okano, Hideyuki, et al.
Publicado: (2014) -
A review of regenerative therapy for spinal cord injury using human iPS cells
por: Kawai, Momotaro, et al.
Publicado: (2022) -
Grafted Human iPS Cell-Derived Oligodendrocyte Precursor Cells Contribute to Robust Remyelination of Demyelinated Axons after Spinal Cord Injury
por: Kawabata, Soya, et al.
Publicado: (2015) -
Purified Mesenchymal Stem Cells Are an Efficient Source for iPS Cell Induction
por: Niibe, Kunimichi, et al.
Publicado: (2011) -
Gene therapy using genome‐edited iPS cells for targeting malignant glioma
por: Tamura, Ryota, et al.
Publicado: (2022)